163 related articles for article (PubMed ID: 26731464)
21. Silver nanoparticles deposited on graphene oxide for ultrasensitive surface-enhanced Raman scattering immunoassay of cancer biomarker.
Yang L; Zhen SJ; Li YF; Huang CZ
Nanoscale; 2018 Jul; 10(25):11942-11947. PubMed ID: 29901677
[TBL] [Abstract][Full Text] [Related]
22. A SERS nano-tag-based fiber-optic strategy for in situ immunoassay in unprocessed whole blood.
Li X; Zhang Y; Xue B; Kong X; Liu X; Tu L; Chang Y; Zhang H
Biosens Bioelectron; 2017 Jun; 92():517-522. PubMed ID: 27836611
[TBL] [Abstract][Full Text] [Related]
23. Dual-Selective and Dual-Enhanced SERS Nanoprobes Strategy for Circulating Hepatocellular Carcinoma Cells Detection.
Pang Y; Wang C; Xiao R; Sun Z
Chemistry; 2018 May; 24(27):7060-7067. PubMed ID: 29521467
[TBL] [Abstract][Full Text] [Related]
24. Highly sensitive immunoassay based on SERS using nano-Au immune probes and a nano-Ag immune substrate.
Shu L; Zhou J; Yuan X; Petti L; Chen J; Jia Z; Mormile P
Talanta; 2014 Jun; 123():161-8. PubMed ID: 24725879
[TBL] [Abstract][Full Text] [Related]
25. Golgi protein 73, not Glypican-3, may be a tumor marker complementary to α-Fetoprotein for hepatocellular carcinoma diagnosis.
Wang Y; Yang H; Xu H; Lu X; Sang X; Zhong S; Huang J; Mao Y
J Gastroenterol Hepatol; 2014 Mar; 29(3):597-602. PubMed ID: 24236824
[TBL] [Abstract][Full Text] [Related]
26. Immunoassay for tumor markers in human serum based on Si nanoparticles and SiC@Ag SERS-active substrate.
Zhou L; Zhou J; Feng Z; Wang F; Xie S; Bu S
Analyst; 2016 Apr; 141(8):2534-41. PubMed ID: 27003871
[TBL] [Abstract][Full Text] [Related]
27. Enzyme-free amplified SERS immunoassay for the ultrasensitive detection of disease biomarkers.
Zhang XX; Xu D; Guo D; Han HX; Li DW; Ma W
Chem Commun (Camb); 2020 Mar; 56(19):2933-2936. PubMed ID: 32040106
[TBL] [Abstract][Full Text] [Related]
28. Ag/SiO2 core-shell nanoparticle-based surface-enhanced Raman probes for immunoassay of cancer marker using silica-coated magnetic nanoparticles as separation tools.
Gong JL; Liang Y; Huang Y; Chen JW; Jiang JH; Shen GL; Yu RQ
Biosens Bioelectron; 2007 Feb; 22(7):1501-7. PubMed ID: 16971110
[TBL] [Abstract][Full Text] [Related]
29. Fluorescence and Scattering Light Cross Correlation Spectroscopy and Its Applications in Homogeneous Immunoassay.
Wang J; Huang X; Liu H; Dong C; Ren J
Anal Chem; 2017 May; 89(10):5230-5237. PubMed ID: 28436659
[TBL] [Abstract][Full Text] [Related]
30. Raman based hepatocellular carcinoma biomarker detection.
Santiago-Cordoba MA; Romano PR; MacKay A; Demirel MC
Annu Int Conf IEEE Eng Med Biol Soc; 2011; 2011():3672-5. PubMed ID: 22255136
[TBL] [Abstract][Full Text] [Related]
31. History and recent progress in evaluation of the fucosylated alpha-fetoprotein fraction.
Aoyagi Y; Tamura Y; Suda T
J Gastroenterol Hepatol; 2011 Apr; 26(4):615-6. PubMed ID: 21418297
[No Abstract] [Full Text] [Related]
32. Abnormal prothrombin (DES-gamma-carboxy prothrombin) in hepatocellular carcinoma.
Nakao A; Virji A; Iwaki Y; Carr B; Iwatsuki S; Starzl E
Hepatogastroenterology; 1991 Oct; 38(5):450-3. PubMed ID: 1722483
[TBL] [Abstract][Full Text] [Related]
33. Quantitative and ultrasensitive detection of multiplex cardiac biomarkers in lateral flow assay with core-shell SERS nanotags.
Zhang D; Huang L; Liu B; Ni H; Sun L; Su E; Chen H; Gu Z; Zhao X
Biosens Bioelectron; 2018 May; 106():204-211. PubMed ID: 29428590
[TBL] [Abstract][Full Text] [Related]
34. Alpha-l-Fucosidase Immunoassay for Early Detection of Hepatocellular Carcinoma.
Waidely E; Al-Youbi AO; Bashammakh AS; El-Shahawi MS; Leblanc RM
Anal Chem; 2017 Sep; 89(17):9459-9466. PubMed ID: 28727913
[TBL] [Abstract][Full Text] [Related]
35. [Focus on a new assay of fucosylated alpha-fetoprotein and evaluation in the biological diagnosis of hepatocellular carcinoma in cirrhosis].
Denis I; Beaudonnet A; Pichot J; Roubille M; Gelineau M
Ann Biol Clin (Paris); 2000; 58(1):85-90. PubMed ID: 10673618
[No Abstract] [Full Text] [Related]
36. Clinical application of specific antibody against glypican-3 for hepatocellular carcinoma diagnosis.
Yu J; Ma Q; Zhang B; Ma R; Xu X; Li M; Xu W; Li M
Sci China Life Sci; 2013 Mar; 56(3):234-9. PubMed ID: 23526389
[TBL] [Abstract][Full Text] [Related]
37. Distinguishing Cancerous Liver Cells Using Surface-Enhanced Raman Spectroscopy.
Huang J; Liu S; Chen Z; Chen N; Pang F; Wang T
Technol Cancer Res Treat; 2016 Feb; 15(1):36-43. PubMed ID: 25432931
[TBL] [Abstract][Full Text] [Related]
38. Silver-amplified fluorescence immunoassay via aggregation-induced emission for detection of disease biomarker.
Sun ZH; Zhang XX; Xu D; Liu J; Yu RJ; Jing C; Han HX; Ma W
Talanta; 2021 Apr; 225():121963. PubMed ID: 33592717
[TBL] [Abstract][Full Text] [Related]
39. A boronate affinity sandwich assay: an appealing alternative to immunoassays for the determination of glycoproteins.
Ye J; Chen Y; Liu Z
Angew Chem Int Ed Engl; 2014 Sep; 53(39):10386-9. PubMed ID: 25088356
[TBL] [Abstract][Full Text] [Related]
40. Development of a competitive radioimmunoassay for glypican-3 and the clinical application in diagnosis of hepatocellular carcinoma.
Zhang Q; Xiao Q; Lin Z; Ying X; Li Z; Lin JM
Clin Biochem; 2010 Aug; 43(12):1003-8. PubMed ID: 20444424
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
